Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to
assemble and peer-review its pathway modules. The integration of ORCID within Reactome
enables us to meet a key challenge with authoring, curating and reviewing biological
information by incentivizing and crediting the external experts that contribute their
expertise and time to the Reactome curation process. More information is available at
ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please
forward this information to us and we will update your Reactome pathway records.
Details on Person Rothfels, Karen, 2021-03-29
| Class:Id | InstanceEdit:9725359 |
| _displayName | Rothfels, Karen, 2021-03-29 |
| _timestamp | 2021-03-29 11:38:29 |
| author | [Person:1226097] Rothfels, Karen |
| dateTime | 2021-03-29 11:38:25 |
| (modified) | [Pathway:201556] Signaling by ALK [Homo sapiens] [Pathway:9700206] Signaling by ALK in cancer [Homo sapiens] [PathwayDiagram:9700218] Diagram of Signaling by ALK, Signaling by ALK fusions and activated point mutants, ALK mutants bind TKIs, ASP-3026- resistant ALK mutants, NVP-TAE684-resistant ALK mutants, alectinib resistant ALK mutants, brigatinib-resistant ALK mutants, ceritinib-resistant ALK mutants, crizotinib-resistant ALK mutants, and lorlatinib-resistant ALK mutants [Summation:9718439] STAT5A expression is repressed in NPM-ALK T-cell lymphomas i... [Summation:9725112] 18-38% percent of neuroblastomas show amplification of the M... [BlackBoxEvent:9725117] ALK gene expression [Homo sapiens] |
|
[Change default viewing format]
|
No pathways have been reviewed or authored by Rothfels, Karen, 2021-03-29 (9725359)